Lærke Egefjord
- Endocrinology, Diabetes and Metabolism top 5%
- Physiology top 10%
- Molecular Biology
- Surgery
- Neurology top 5%
- Co-authors
- Jørgen RungbyBirgitte BrockMichael GejlAlbert GjeddeKim VangArne MøllerHans BrændgaardHanne Gottrup
- Topics
- Diabetes Treatment and Management (5 papers)Diet and metabolism studies (3 papers)Alzheimer's disease research and treatments (2 papers)
- Partner nations
- DenmarkUnited StatesCanada
In The Last Decade
Lærke Egefjord
10 papers receiving 826 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 370
- Physiology 331
- Molecular Biology 191
- Surgery 166
- Neurology 146
Countries citing papers authored by Lærke Egefjord
This map shows the geographic impact of Lærke Egefjord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lærke Egefjord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lærke Egefjord more than expected).
Fields of papers citing papers by Lærke Egefjord
This network shows the impact of papers produced by Lærke Egefjord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lærke Egefjord. The network helps show where Lærke Egefjord may publish in the future.
Co-authorship network of co-authors of Lærke Egefjord
This figure shows the co-authorship network connecting the top 25 collaborators of Lærke Egefjord. A scholar is included among the top collaborators of Lærke Egefjord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lærke Egefjord. Lærke Egefjord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 124 | |
| 2 | 81 | |
| 3 | In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trialbreakdown → | 346 |
| 4 | 27 | |
| 5 | Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial. | 70 |
| 6 | 41 | |
| 7 | 32 | |
| 8 | 28 | |
| 9 | 38 | |
| 10 | 47 |
About Lærke Egefjord
Lærke Egefjord is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Nutrition and Dietetics, having authored 10 papers that have together received 834 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Diet and metabolism studies (3 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (370 citations), Neurology (146 citations) and Physiology (331 citations). Lærke Egefjord has collaborated with scholars based in Denmark, United States and Canada. Frequent co-authors include Jørgen Rungby, Birgitte Brock, Michael Gejl, Albert Gjedde, Kim Vang, Arne Møller, Hans Brændgaard, Hanne Gottrup, Niels Møller and Anders Rodell. Their work appears in journals such as Scientific Reports, Journal of Cerebral Blood Flow & Metabolism and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.